April 16 (Reuters) - Xtant Medical Holdings Inc XTNT.A:
XTANT MEDICAL ANNOUNCES SECONDARY PRIVATE SALE OF EXISTING SHARES BY ORBIMED AND PRELIMINARY FIRST QUARTER 2025 REVENUE GROWTH OF 18% TO 19%
XTANT MEDICAL HOLDINGS INC OUTLOOK Q1 REVENUE $32.8 MILLION AND $33.1 MILLION
Source text: ID:nPn8wMQLDa
Further company coverage: XTNT.A
((Reuters.Briefs@thomsonreuters.com;))
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。